Daphne Karydas sold $86K of MLYS stock

Daphne Karydas, Dir of Mineralys Therapeutics, Inc. (MLYS), sold 3,000 shares of MLYS stock worth $86K, per an SEC Form 4 filed Sep 17, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 15, 2026, 2 days before it was made public.

MLYS has moved -47.0% since the trade date, from $28.91 to $15.33 (Nov 6, 2026 close).